Status: current, Defined. Date: 31-May 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2381691000168118 | Durolane (hyaluronic acid 20 mg / 1 mL) injection, 1 x 3 mL syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2381701000168118 | Durolane 20 mg/mL injection, 3 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Durolane 20 mg/mL injection, 3 mL syringe | Is a | hyaluronic acid 20 mg/mL injection, 3 mL syringe | true | Inferred relationship | Some | ||
| Durolane 20 mg/mL injection, 3 mL syringe | Is a | trade product pack | true | Inferred relationship | Some | ||
| Durolane 20 mg/mL injection, 3 mL syringe | has TPUU | Durolane (hyaluronic acid 20 mg / 1 mL) injection, 3 mL syringe (trade product unit of use) | true | Inferred relationship | Some | 1 | |
| Durolane 20 mg/mL injection, 3 mL syringe | has TP | Durolane | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Durolane 20 mg/mL injection, 3 mL syringe | Is a | True | Durolane 20 mg/mL injection, 3 mL syringe | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR